Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

Autor: Chakrabarti, Anjan K., Feeney, Kristin, Abueg, Cassandra, Brown, David A., Czyz, Ewa, Tendera, Michal, Janosi, Andras, Giugliano, Robert P., Kloner, Robert A., Weaver, W. Douglas, Bode, Christoph, Godlewski, Jacek, Merkely, Bela, Gibson, C. Michael
Zdroj: In American Heart Journal April 2013 165(4):509-514
Databáze: ScienceDirect
Externí odkaz: